SGMS2 (sphingomyelin synthase 2)

2003-05-01  

Identity

HGNC
LOCATION
4q25
LOCUSID
ALIAS
CDL,SMS2

Other Information

Locus ID:

NCBI: 166929
MIM: 611574
HGNC: 28395
Ensembl: ENSG00000164023

Variants:

dbSNP: 166929
ClinVar: 166929
TCGA: ENSG00000164023
COSMIC: SGMS2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000164023ENST00000359079Q8NHU3
ENSG00000164023ENST00000359079A0A024RDH4
ENSG00000164023ENST00000394684Q8NHU3
ENSG00000164023ENST00000394684A0A024RDH4
ENSG00000164023ENST00000394686Q8NHU3
ENSG00000164023ENST00000394686A0A024RDH4
ENSG00000164023ENST00000503385E5RGG5
ENSG00000164023ENST00000503862E5RJU3
ENSG00000164023ENST00000506993E5RJ63

Expression (GTEx)

0
5
10
15
20
25

Pathways

PathwaySourceExternal ID
Sphingolipid metabolismKEGGko00600
Sphingolipid metabolismKEGGhsa00600
Metabolic pathwaysKEGGhsa01100
Sphingolipid signaling pathwayKEGGhsa04071
Sphingolipid signaling pathwayKEGGko04071
MetabolismREACTOMER-HSA-1430728
Metabolism of lipids and lipoproteinsREACTOMER-HSA-556833
Sphingolipid metabolismREACTOMER-HSA-428157
Sphingolipid de novo biosynthesisREACTOMER-HSA-1660661

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
378494292024Identification of SGMS2 as a molecule involved in natural killer cell recruitment and its in-deep analysis in the liver cancer microenvironment: Evidence from large populations cohort.0
382850902024Sphingomyelin synthase 2 promotes the stemness of breast cancer cells via modulating NF-κB signaling pathway.0
378494292024Identification of SGMS2 as a molecule involved in natural killer cell recruitment and its in-deep analysis in the liver cancer microenvironment: Evidence from large populations cohort.0
382850902024Sphingomyelin synthase 2 promotes the stemness of breast cancer cells via modulating NF-κB signaling pathway.0
366910442023LARP6 suppresses colorectal cancer progression through ZNF267/SGMS2-mediated imbalance of sphingomyelin synthesis.3
371757372023Clinical and Genetic Characteristics of Calvarial Doughnut Lesions with Bone Fragility in Three Families with a Reccurent SGMS2 Gene Variant.0
378866442023SGMS2 in primary osteoporosis with facial nerve palsy.0
366910442023LARP6 suppresses colorectal cancer progression through ZNF267/SGMS2-mediated imbalance of sphingomyelin synthesis.3
371757372023Clinical and Genetic Characteristics of Calvarial Doughnut Lesions with Bone Fragility in Three Families with a Reccurent SGMS2 Gene Variant.0
378866442023SGMS2 in primary osteoporosis with facial nerve palsy.0
324514132021Sphingomyelin synthase 2 facilitates M2-like macrophage polarization and tumor progression in a mouse model of triple-negative breast cancer.22
337277492021Genome-wide association study of serum prostate-specific antigen levels based on 1000 Genomes imputed data in Japanese: the Japan Multi-Institutional Collaborative Cohort Study.1
342738042021LncRNA THAP9-AS1 accelerates cell growth of esophageal squamous cell carcinoma through sponging miR-335-5p to regulate SGMS2.7
324514132021Sphingomyelin synthase 2 facilitates M2-like macrophage polarization and tumor progression in a mouse model of triple-negative breast cancer.22
337277492021Genome-wide association study of serum prostate-specific antigen levels based on 1000 Genomes imputed data in Japanese: the Japan Multi-Institutional Collaborative Cohort Study.1

Citation

Dessen P

SGMS2 (sphingomyelin synthase 2)

Atlas Genet Cytogenet Oncol Haematol. 2003-05-01

Online version: http://atlasgeneticsoncology.org/gene/41354/sgms2-(sphingomyelin-synthase-2)